The PD-L1 (also known as CD274) expressed by tumor cells plays a crucial role in the mediation of immunosuppression [62], and its expression level in tumor cells has a potential relationship to objective response of immunotherapy of ccRCC, such as anti-PD1 inhibitors [63]. The gene discussed is PDCD1; the disease is neoplasm.